A Registry for Patients Taking Uptravi (SPHERE)
view all Clinical Trials
This is a US multi-center, prospective, real world, observational drug registry enrolling patients actively treated with Uptravi. Participating patients will be followed prospectively for a maximum of 18 months from the date of enrollment into the registry.
For more information about this trial or to inquire about eligibility, email firstname.lastname@example.org or call 215-707-1359.